Patient characteristics
| Characteristics | n | |
|---|---|---|
| Patients | 63 | |
| Fully assessable patients | 60 | |
| Sex (men/women) | 39/24 | |
| Age (y) | ||
| Median | 56 | |
| Range | 19-79 | |
| Eastern Cooperative Oncology Group performance status, patients | ||
| 0 | 20 | |
| 1 | 30 | |
| 2 | 13 | |
| Prior therapy, patients | ||
| Chemotherapy alone | 58 | |
| Radiotherapy alone | 2 | |
| Chemotherapy and radiotherapy | 28 | |
| Tumor type, patients | ||
| Renal | 16 | |
| Colorectal | 10 | |
| Non–small cell lung cancer | 9 | |
| Soft-tissue sarcoma | 7 | |
| Endometrial | 3 | |
| Ovarian | 2 | |
| Sarcoma | 2 | |
| Other* | 14 | |
↵* One each of anaplastic astrocytoma, cervical, esophageal, gastric, head and neck-adenoid cystic carcinoma, hepatocellular, non-Hodgkin's lymphoma, nasopharyngeal, osteosarcoma, pancreatic, prostate, squamous cell carcinoma of the skin, thyroid, and unknown.